These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38256370)

  • 21. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
    Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
    Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction.
    Chen C; Cheng K; Gao X; Zou T; Pang Y; Ling Y; Xu Y; Xu Y; Chen Q; Zhu W; Ge J
    ESC Heart Fail; 2023 Feb; 10(1):518-531. PubMed ID: 36325978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry.
    Zafrir B; Lund LH; Laroche C; Ruschitzka F; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Seferovic PM; Maggioni AP; De Mora Martin M; Polonski L; Silva-Cardoso J; Amir O;
    Eur Heart J; 2018 Dec; 39(48):4277-4284. PubMed ID: 30325423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left atrium decompression devices across the spectrum of ejection fraction in heart failure: an updated systematic review and meta-regression analysis.
    Basile C; Paolillo S; Gargiulo P; Marzano F; Dellegrottaglie S; Abbate V; Ambrosio A; Carbone F; Dell'Aversana S; Esposito I; Fierro MF; Perrone-Filardi P
    Heart Fail Rev; 2023 Sep; 28(5):1151-1161. PubMed ID: 37162633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
    Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
    Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.
    Teramoto K; Tay WT; Tromp J; Katherine Teng TH; Chandramouli C; Ouwerkerk W; Lawson CA; Huang W; Hung CL; Chopra V; Anand I; Mark Richards A; Lam CSP
    Circ Cardiovasc Qual Outcomes; 2023 Jan; 16(1):e009134. PubMed ID: 36484254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
    Liang M; Bian B; Yang Q
    Clin Cardiol; 2022 Jan; 45(1):5-17. PubMed ID: 35043472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(13):1-60. PubMed ID: 23074464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcomes of young and very young adults with heart failure: The CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity).
    Wong CM; Hawkins NM; Jhund PS; MacDonald MR; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; McMurray JJ
    J Am Coll Cardiol; 2013 Nov; 62(20):1845-54. PubMed ID: 23850914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term changes in health-related quality of life for people with heart failure: the ECHOES study.
    Roalfe AK; Taylor CJ; Hobbs FDR
    ESC Heart Fail; 2023 Feb; 10(1):211-222. PubMed ID: 36184768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'It could be worse ... lot's worse!' Why health-related quality of life is better in older compared with younger individuals with heart failure.
    Moser DK; Heo S; Lee KS; Hammash M; Riegel B; Lennie TA; Arslanian-Engoren C; Mudd-Martin G; Albert N; Watkins J
    Age Ageing; 2013 Sep; 42(5):626-32. PubMed ID: 23832262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.
    Gastelurrutia P; Lupón J; Moliner P; Yang X; Cediel G; de Antonio M; Domingo M; Altimir S; González B; Rodríguez M; Rivas C; Díaz V; Fung E; Zamora E; Santesmases J; Núñez J; Woo J; Bayes-Genis A
    Mayo Clin Proc Innov Qual Outcomes; 2018 Jun; 2(2):176-185. PubMed ID: 30225447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical Function, and Patient-Reported Outcomes in Adults With Preserved Ejection Fraction Heart Failure.
    Alonso WW; Kupzyk KA; Norman JF; Lundgren SW; Fisher A; Lindsey ML; Keteyian SJ; Pozehl BJ
    J Card Fail; 2022 Mar; 28(3):431-442. PubMed ID: 34534664
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.